Earlier this week, I told you about six men who were hospitalized in critical condition following a clinical drug trial conducted in the UK by American drugmaker Parexel. The news is good for two patients, who left a London hospital, after making what doctors called "an excellent recovery."
But it's not so great for the rest of them. One patient remains in critical condition and the rest are making progress, albeit more slowly.
You'd think TeGenero, the company that developed the anti-inflammatory TGN1412, would've paid attention to its own animal studies (the glands of two monkeys became swollen after taking the experimental drug).
Just another reason to consider safer, healthy ways to treat your pain without taking a prescription drug or a "tried and true" over-the-counter remedy like aspirin.
BBC News March 28, 2006